Skip to main content

Table 3 VAS improvement (FAS)

From: Nalfurafine hydrochloride for refractory pruritus in peritoneal dialysis patients: a phase III, multi-institutional, non-controlled, open-label trial

  Treatment period week 1
(days 1–7)
(N = 37)
Treatment period week 2
(days 8–14)
(N = 36)
Treatment period week 3
(days 15–21)
(N = 35)
Treatment period week 4
(days 22–28)
(N = 35)
Follow-up period week 1
(days 1–8)
(N = 36)
Improved patients (%) [95% CI] 11 (29.7) [15.9, 47.0] 18 (50.0) [32.9, 67.1] 22 (62.9) [44.9, 78.5] 22 (62.9) [44.9, 78.5] 19 (52.8) [35.5, 69.6]